Document Detail


Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.
MedLine Citation:
PMID:  8606288     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study evaluated the role of changes in heart rate, cardiac filling pressures and cardiac tissue atrial and brain natriuretic peptides in the modulation of their plasma levels in a model of heart failure. BACKGROUND: Atrial and brain natriuretic peptides constitute a dual natriuretic peptide system that regulates circulatory homeostasis. METHODS: The effects of 1) acute ventricular pacing, 2) acute volume expansion, and 3) volume expansion after 1 week of continuous pacing on plasma atrial and brain natriuretic peptide levels were compared in eight dogs. Atrial and ventricular tissue levels of the peptides were examined in 5 normal dogs (control group), 21 dogs paced for 1 week (group 1) and 10 dogs paced for 3 weeks (group 2). RESULTS: Both acute pacing and volume expansion increased plasma atrial natriuretic peptide levels (from 53 +/- 41 to 263 +/- 143 pg/ml [mean +/- SD], p < 0.01, and from 38 +/- 23 to 405 +/- 221 pg/ml, p < 0.001, respectively). After 1 week, there was a marked increase in plasma levels of atrial natriuretic peptide, but the level did not increase further with volume expansion (from 535 +/- 144 to 448 +/- 140 pg/ml, p = 0.72). By contrast, plasma brain natriuretic peptide levels increased only modestly with acute pacing (from 12 +/- 4 to 20 +/- 8 pg/ml, p < 0.05) and after pacing for 1 week (from 13 +/- 4 to 48 +/- 20 pg/ml, p < 0.05) but did not change with acute or repeat volume expansion. In groups 1 and 2, atrial tissue levels of atrial natriuretic peptide (1.9 +/- 1.3 and 2.0 +/- 0.9 ng/mg, respectively) were lower than those in the control group (11.7 +/- 6.8 ng/mg, both p < 0.001), whereas ventricular levels were similar to those in the control group. Atrial tissue brain natriuretic peptide levels in groups 1 and 2 were similar to those in the control group. However, ventricular levels in group 2 (0.018 +/- 0.006 ng/mg) were increased compared with those in the control group (0.013 +/- 0.006 ng/mg, p < 0.05) and in group 1 (0.011 +/- 0.006 ng/mg, p < 0.05). CONCLUSIONS: Atrial and brain natriuretic peptides respond differently to changes in heart rate and atrial pressures. Reduced atrial tissue atrial natriuretic peptide levels in heart failure may indicate reduced storage after enhanced cardiac release. However, the relatively modest change in cardiac tissue brain natriuretic peptide levels suggests that the elevated plasma levels may be mediated by mechanisms other than increased atrial pressures.
Authors:
G W Moe; E A Grima; N L Wong; R J Howard; P W Armstrong
Related Documents :
8922918 - Diastolic dysfunction and natriuretic peptides in systolic heart failure. higher anp an...
1825258 - Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation...
7485568 - Relationship of simultaneous atrial and ventricular pressures in stage 16-27 chick embr...
4412838 - Discharge of type b atrial receptors during changes in vascular volume and depression o...
8817978 - Pharmacologically induced heart failure for the evaluation of circulatory assistance.
3458248 - Contact pressures in the human hip joint measured in vivo.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  27     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-05-22     Completed Date:  1996-05-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  720-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Atrial Natriuretic Factor / blood,  metabolism*
Cardiac Pacing, Artificial
Chronic Disease
Dextrans / pharmacology
Disease Models, Animal
Dogs
Heart Failure / blood*,  pathology*,  physiopathology
Hemodynamics
Myocardium / metabolism*
Natriuretic Peptide, Brain
Nerve Tissue Proteins / blood,  metabolism*
Plasma Substitutes / pharmacology
Chemical
Reg. No./Substance:
0/Nerve Tissue Proteins; 0/Plasma Substitutes; 114471-18-0/Natriuretic Peptide, Brain; 85637-73-6/Atrial Natriuretic Factor; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Survival after myocardial infarction in rats: captopril versus losartan.
Next Document:  Altered inotropic and lusitropic responses to heart rate in conscious dogs with tachycardia-induced ...